Mutation-signature–associated metrics predict cancer progression in patients

By | June 28, 2021
Oncotarget published “Predicting clinical outcomes using cancer progression associated signatures” which reported somatic mutation signatures are an informative facet of cancer etiology, however they are rarely useful for predicting patient outcome.